Latest filing published 09 Jun 2026 for Anteris Technologies Global CORP.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David B. Roberts (chief executive) discloses dealings in 2 companies, chiefly Lemaitre Vascular Inc and Anteris Technologies Global Corp. We count 47 filings; the first trade dates from 8 January 2016 and the latest from 7 June 2026.
Every open-market trade on record is a sale: 8 sales worth €1.5M. The totals do not cover 5 filings with an undisclosed amount. Other entries cover 9 share grants and 30 option exercises. Since January 2026: no purchases and 1 sale on the market.
The record was last updated on 9 June 2026 with an option exercise in Anteris Technologies Global Corp. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 47 declarations